Fatal pulmonary hemorrhage after taking anticoagulation medication
نویسندگان
چکیده
منابع مشابه
Fatal pulmonary hemorrhage after taking anticoagulation medication
We describe a 64-year-old man with extensive diffuse acute lung hemorrhage, presumably as a result of anticoagulation therapy. We evaluated reports in the literature concerning acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. We also evaluated autopsy tissue in this case in order to determine the cause of death in this 64-year-o...
متن کاملMechanisms of fatal pulmonary hemorrhage in tuberculosis.
Fatal hemorrhage Is not an uncommon mode of exitus in patients afflicted with pulmonary tuberculosis. Perhaps the most disturbing feature is that many of the individuals who are stricken have passed the acute phase of their illness and apparently are on the road to recovery. The incidence of fatal hemorrhage has been estimated by different authors to be from 1 to 5 per cent.’ A survey of 2,500 ...
متن کاملEmergency reversal of anticoagulation after intracerebral hemorrhage.
BACKGROUND AND PURPOSE Although intracerebral hemorrhage is one of the most serious complications during oral anticoagulant therapy, there are no guidelines on emergency treatment with respect to reversal of anticoagulation effect in these patients. METHODS We retrospectively compared laboratory data and clinical features in 17 cases of anticoagulant-related intracerebral hemorrhage treated w...
متن کاملShould anticoagulation be resumed after intracerebral hemorrhage?
Intracerebral hemorrhage (ICH) is the most feared and the most deadly complication of oral anticoagulant therapy, eg, with warfarin (Coumadin). After such an event, clinicians wonder whether their patients should resume anticoagulant therapy. The authors review the management of anticoagulation during and after anticoagulation-associated ICH.
متن کاملResuming anticoagulation after hemorrhage: A practical approach.
Most patients who suffer a hemorrhage while on long-term anticoagulant therapy continue to be at risk of thrombosis. Physicians often need to reconsider the need for anticoagulation in view of the risk of recurrent bleeding, and when anticoagulation needs to be resumed, they must also consider the timing and strategy. Since there are no evidence-based guidelines for these situations, the author...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Respiratory Medicine Case Reports
سال: 2015
ISSN: 2213-0071
DOI: 10.1016/j.rmcr.2015.05.010